Bausch Health Companies | VRX - SCHULD





SCHULD Veränderung Datum
Amgen USD 57.32B 2.72B 2026-03
ANI Pharmaceuticals USD 613.76M 3.28M 2026-03
Aurora Cannabis CAD 23.86M 76.48M 2026-03
Bausch Health Companies USD 20.78B 16M 2026-06
Biogen USD 8.09B 1.53B 2026-06
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Canopy Growth CAD 278.71M 19.38M 2026-03
Corcept Therapeutics USD 9.64M 3.53M 2026-03
Danaher USD 26.56B 8.07B 2026-06
Drreddys Laboratories INR 77.34B 9.61B 2026-03
Eli Lilly USD 43.37B 867M 2026-03
Gilead Sciences USD 22.17B 2.76B 2026-03
Nektar Therapeutics USD 0 0 2022-06
Novo Nordisk DKK 118.72B 61.75B 2025-03
Pacira USD 363.12M 4.53M 2026-06
Perrigo USD 3.63B 7.7M 2026-03
Phibro Animal Health USD 474.17M 730K 2024-09
Prestige Brands USD 1.05B 33.86M 2026-03
Supernus Pharmaceuticals USD 40.17M 733K 2026-06
Vertex Pharmaceuticals USD 1.98B 8.9M 2026-06
Zoetis USD 9.24B 0 2026-03